Sarepta Therapeutics
NASDAQ: SRPT
$162.75
-$2.93 (-1.8%)
Closing price July 2, 2020
Selecta Biosciences and Sarepta Therapeutics have announced that they had entered into a research license and option agreement.
16 days ago
Here are the biotech companies with exposure to experimental vaccines whose shares saw the biggest boost from this past week's coronavirus news.
5 months ago
Last Updated: 5 months ago
China is facing an outbreak of the coronavirus, which may have spread to a few other countries in Asia. As a result, experimental vaccine stocks are skyrocketing.
5 months ago
Last Updated: 5 months ago
Sarepta shares jumped last week on news that the company reached a licensing deal with Roche. While investors saw about a five-point bump from this news, one analyst sees much more upside for this...
6 months ago
Last Updated: 5 months ago
Christmas Eve's top analyst upgrades, downgrades and initiations included Amgen, Apple, Builder FirstSource, CarMax, Dominion Energy, FedEx, Nike, Regeneron Pharmaceuticals and Sarpeta Therapeutics.
6 months ago
Last Updated: 5 months ago
Sarepta Therapeutics shares made a handy gain to start the week after it announced a licensing agreement with Roche for its investigational gene therapy for Duchenne muscular dystrophy.
6 months ago
Last Updated: 5 months ago
Sarepta shares jumped on Friday after the firm announced that the FDA has approved Vyondys 53 (golodirsen) for the treatment of Duchenne muscular dystrophy (DMD) in certain patients.
6 months ago
Last Updated: 5 months ago
The top analyst upgrades, downgrades and initiations for Friday included Adobe, Biogen, Bristol-Myers, Broadcom, Charles Schwab, Ciena, Etsy, Gilead, Oracle, Sarepta, Snap and Wayfair.
6 months ago
Last Updated: 5 months ago
Friday's top analyst upgrades, downgrades and initiations included Arista Networks, Booking, Dunkin' Brands, DuPont, GameStop, Generac, PBF Energy, Pinterest, Square and YETI.
8 months ago
Last Updated: 5 months ago
Sarepta shares jumped on Friday after the firm announced an update from its Duchenne muscular dystrophy trial.
9 months ago
Last Updated: 5 months ago
One sector that has avoided much of the current trade and recession fear turmoil is health care, and especially the biotech companies. The four top stocks have gigantic implied upside.
10 months ago
Last Updated: 5 months ago
Tuesday was a breakout day for a few biotech companies that saw either huge gains or massive losses. 24/7 Wall St. has picked a few of those standouts to highlight.
10 months ago
Last Updated: 5 months ago
The included AbbVie, Beyond Meat, Bio-Rad Laboratories, Dell Technologies, HP, Jumia Technologies, Nabriva Therapeutics, PG&E, Salesforce.com and Sarepta Therapeutics.
10 months ago
Last Updated: 5 months ago
With the market clearly close to, or at full value, it makes sense to look to areas where alpha can be generated for the rest of 2019. These five top stocks are the best picks from the Merrill team...
11 months ago
Last Updated: 5 months ago
With the three major stock indexes trading at or near all-time highs, many investors are scratching their heads about where to look for new investment ideas at a time when interest rates have become...
1 year ago
Last Updated: 5 months ago